ST7 Antibody (C-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP6251a
Background:
ST7 was identified by its differential expression in cancer cells. The product of this gene is predicted to be a transmembrane protein. The level of this protein was found to be lower in tumor derived cell lines compared to normal cells. This protein has thus been proposed to be a candidate tumor suppressor gene.
Other Names:
Low-density lipoprotein receptor-related protein 12, LRP-12, Suppressor of tumorigenicity 7 protein, LRP12, ST7
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6251a was selected from the C-term region of human ST7 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: LRP12
Gene ID: 29967
Primary Accession: Q9Y561
Other Accession: NP_038465
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
ST7 was identified by its differential expression in cancer cells. The product of this gene is predicted to be a transmembrane protein. The level of this protein was found to be lower in tumor derived cell lines compared to normal cells. This protein has thus been proposed to be a candidate tumor suppressor gene.
Other Names:
Low-density lipoprotein receptor-related protein 12, LRP-12, Suppressor of tumorigenicity 7 protein, LRP12, ST7
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6251a was selected from the C-term region of human ST7 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: LRP12
Gene ID: 29967
Primary Accession: Q9Y561
Other Accession: NP_038465
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review